Preference of DNA Methyltransferases for CpG Islands in Mouse Embryonic Stem Cells
Overview
Authors
Affiliations
Many CpG islands have tissue-dependent and differentially methylated regions (T-DMRs) in normal cells and tissues. To elucidate how DNA methyltransferases (Dnmts) participate in methylation of the genomic components, we investigated the genome-wide DNA methylation pattern of the T-DMRs with Dnmt1-, Dnmt3a-, and/or Dnmt3b-deficient ES cells by restriction landmark genomic scanning (RLGS). Approximately 1300 spots were detected in wild-type ES cells. In Dnmt1(-/-) ES cells, additional 236 spots emerged, indicating that the corresponding loci are methylated by Dnmt1 in wild-type ES cells. Intriguingly, in Dnmt3a(-/-)Dnmt3b(-/-) ES cells, the same 236 spots also emerged, and no additional spots appeared differentially. Therefore, Dnmt1 and Dnmt3a/3b share targets in CpG islands. Cloning and virtual image RLGS revealed that 81% of the RLGS spots were associated with genes, and 62% of the loci were in CpG islands. By contrast to the previous reports that demethylation at repeated sequences was severe in Dnmt1(-/-) cells compared with Dnmt3a(-/-)Dnmt3b(-/-) cells, a complete loss of methylation was observed at RLGS loci in Dnmt3a(-/-)Dnmt3b(-/-) cells, whereas methylation levels only decreased to 16% to 48% in the Dnmt1(-/-) cells. We concluded that there are CpG islands with T-DMR as targets shared by Dnmt1 and Dnmt3a/3b and that each Dnmt has target preferences depending on the genomic components.
Epigenetic regulation of matrix metalloproteinases in inflammatory diseases: a narrative review.
He J, Qin M, Chen Y, Hu Z, Xie F, Ye L Cell Biosci. 2020; 10:86.
PMID: 32695308 PMC: 7368751. DOI: 10.1186/s13578-020-00451-x.
The Genomic Impact of DNA CpG Methylation on Gene Expression; Relationships in Prostate Cancer.
Long M, Smiraglia D, Campbell M Biomolecules. 2017; 7(1).
PMID: 28216563 PMC: 5372727. DOI: 10.3390/biom7010015.
DNA methylation in hematopoietic development and disease.
Gore A, Weinstein B Exp Hematol. 2016; 44(9):783-790.
PMID: 27178734 PMC: 4992597. DOI: 10.1016/j.exphem.2016.04.013.
Epigenetics: A primer for clinicians.
Paluch B, Naqash A, Brumberger Z, Nemeth M, Griffiths E Blood Rev. 2016; 30(4):285-95.
PMID: 26969414 PMC: 5737767. DOI: 10.1016/j.blre.2016.02.002.
DNMT3A in haematological malignancies.
Yang L, Rau R, Goodell M Nat Rev Cancer. 2015; 15(3):152-65.
PMID: 25693834 PMC: 5814392. DOI: 10.1038/nrc3895.